Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N.
Tanaka M, et al. Among authors: araki r.
Diabetes Metab. 2019 Jan;45(1):86-89. doi: 10.1016/j.diabet.2017.06.006. Epub 2017 Jul 31.
Diabetes Metab. 2019.
PMID: 28774784
No abstract available.